Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...
Taipei Times

Cancer diagnosis rates increasing, HPA data show

Taiwan’s “cancer clock” sped up by 14 seconds in 2023, indicating a diagnosis every 3 minutes, 48 seconds, with lung cancer remaining the most commonly diagnosed cancer among men and women, the ...

Verastem: Downgrading To Buy Based On RAMP-203 Setback In Targeting KRAS G12C NSCLC

Verastem, Inc. shifts focus to VS-7375 for KRAS G12D tumors after ending RAMP-203. Click to learn about VSTM's key catalysts ...
Taipei Times

Cancer cases rising, in part due to early detection: HPA

Taiwan recorded 138,051 new cancer cases in 2023, 7,758 more than in 2022, the Health Promotion Administration (HPA) reported ...